Stay in Touch
Get sneak previews of special offers & upcoming events delivered to your inbox.
Sign in
12-29-2021 05:38 PM - edited 12-29-2021 05:50 PM
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the comp
View Product PhotosFOR IMMEDIATE RELEASE – 12/28/2021 – Cranford, New Jersey, Viona Pharmaceuticals Inc., is voluntarily recalling thirty three (33) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. Reason for the recall is an Out of specification result observed for the said product, Lot number M008132, “N-nitrosodimethylamine (NDMA) (By GC-MS/MS)” test at 17 Month(s), 25°C/60%RH Long-term stability samples. As a precautionary measure firm voluntarily recall all the marketed 33 batches having valid shelf life. This product was manufactured by Cadila Healthcare Limited, Ahmedabad, India for U.S. distribution by Viona Pharmaceuticals Inc.
Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables. Patients who have received impacted lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg are advised to continue taking their medication and contact their physician for advice regarding an alternative treatment. According to the FDA, it could be dangerous for patients with this serious condition to stop taking their Metformin without first talking to their healthcare professionals. Please visit the agency’s website for more information at https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-metf.... To date, neither Viona Pharmaceuticals Inc., nor Cadila Healthcare Limited have received any reports of adverse events related to this recall.
The product is used as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus and is packaged in HDPE bottles of 100 tablets, under NDC 72578-036-01. Firm recalled Metformin Hydrochloride Extended-Release Tablets, USP 750 mgare listed in the below table. The product can be identified as white to off-white, capsule shaped, uncoated tablets, debossed with "Z", "C" on one side and "20" on the other side. Metformin Hydrochloride Extended-Release Tablets, USP 750 mg was distributed Nationwide to Distributors.
Product Name: Metformin Hydrochloride Extended-Release Tablets, USP 750 mg
NDC: 72578-036-01
1. | M008130 | 06/2022 |
2. | M008131 | 06/2022 |
3. | M008132 | 06/2022 |
4. | M008133 | 06/2022 |
5. | M010080 | 07/2022 |
6. | M010081 | 07/2022 |
7. | M011029 | 08/2022 |
8. | M011030 | 08/2022 |
9. | M011031 | 08/2022 |
10. | M011032 | 08/2022 |
11. | M011304 | 08/2022 |
12. | M013394 | 09/2022 |
13. | M013395 | 09/2022 |
14. | M013396 | 09/2022 |
15. | M013966 | 09/2022 |
16. | M013967 | 09/2022 |
17. | M100831 | 12/2022 |
18. | M100832 | 12/2022 |
19. | M100833 | 01/2023 |
20. | M100834 | 01/2023 |
21. | M101267 | 01/2023 |
22. | M102718 | 01/2023 |
23. | M102719 | 01/2023 |
24. | M102720 | 01/2023 |
25. | M102721 | 02/2023 |
26. | M102722 | 02/2023 |
27. | M104172 | 02/2023 |
28. | M104173 | 02/2023 |
29. | M104174 | 02/2023 |
30. | M104175 | 02/2023 |
31. | M104176 | 02/2023 |
32. | M105889 | 03/2023 |
33. | M105890 | 03/2023 |
Viona Pharmaceuticals Inc., is notifying its customers by email and mail (FedEx Overnight) and is arranging for return of all recalled products to our recall processor at the following address
Eversana Life Science Services
c/o Viona recall
ATTN: Returns Department
4580 S. Mendenhall Rd.
Memphis, TN 38141
Consumers with questions regarding this recall can contact our recall processor Eversana Life Science Services by phone at 1-888-304-5022, option 1; Monday – Friday, 8:00 am – 7:00 pm CDT. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Customers with medical-related questions, who wish to report an adverse event, or quality issues about the products being recalled should contact Viona Pharmaceuticals Inc., by phone at: 888-304-5011, Monday - Friday, 8:30 am – 5:30 pm, EST.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
12-29-2021 05:54 PM
12-29-2021 05:56 PM
This is the pill used to treat type 2 diabetes correct?
12-29-2021 06:22 PM
Thank you for keeping us on our toes for all of these recalls, they seem to be coming fast and furiously lately!
12-29-2021 07:40 PM - edited 12-29-2021 07:43 PM
@icezeus @Yes. A variety of medications used to treat many diseases have been found to contain NDMA in the last few years. Zantac and some blood pressure medications are some other medicines that have been recalled because of the contaminant. This substance has also been found in cured meats, beer, whiskey, cheeses, other foods and drinking water. It has an environmental relationship with rocket fuel. It is found in our air, soil and water now.
Get sneak previews of special offers & upcoming events delivered to your inbox.
*You're signing up to receive QVC promotional email.
Find recent orders, do a return or exchange, create a Wish List & more.
Privacy StatementGeneral Terms of Use
QVC is not responsible for the availability, content, security, policies, or practices of the above referenced third-party linked sites nor liable for statements, claims, opinions, or representations contained therein. QVC's Privacy Statement does not apply to these third-party web sites.
© 1995-2024 QVC, Inc. All rights reserved. | QVC, Q and the Q logo are registered service marks of ER Marks, Inc. 888-345-5788